Form EFFECT Aspira Women's Health
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dr. Dayan Goodenowe Takes the Cover of TopDoctor Magazine, Revealing a New Vision for the Future of Health
- New Crypto Pepeto Announces It Is Live on CoinMarketCap as a Binance Listing Nears and Cardano Price Prediction Targets $5
- Wiwynn Showcases Next-Gen AI Platforms, Thermal Engineering, and Optical Interconnect Technologies at 2026 OCP Global Summit
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share